ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.38
0.74%
US Tech 100
20,836.00
1.31%
S&P 500
5,930.85
1.09%
US Dollar vs CAD
1.43421
0.00%
Bitcoin
96,652.11
-0.57%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Eton Pharmaceuticals Inc (ETON)

  7. Eton Pharmaceuticals Inc (ETON) News

ETON

Eton Pharmaceuticals (ETON)

Eton Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ETON
DateTimeSourceHeadlineSymbolCompany
12/20/20246:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
12/20/20245:50AMGlobeNewswire Inc.Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)NASDAQ:ETONEton Pharmaceuticals Inc
12/17/20246:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
12/17/20245:50AMGlobeNewswire Inc.Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical TrialNASDAQ:ETONEton Pharmaceuticals Inc
12/12/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
12/12/20243:27PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ETONEton Pharmaceuticals Inc
12/09/20244:11PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ETONEton Pharmaceuticals Inc
12/03/20246:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
12/03/20245:50AMGlobeNewswire Inc.Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial OfficerNASDAQ:ETONEton Pharmaceuticals Inc
11/25/20246:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
11/25/20245:50AMGlobeNewswire Inc.Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)NASDAQ:ETONEton Pharmaceuticals Inc
11/12/20243:25PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ETONEton Pharmaceuticals Inc
11/12/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
11/12/20243:01PMGlobeNewswire Inc.Eton Pharmaceuticals Reports Third Quarter 2024 Financial ResultsNASDAQ:ETONEton Pharmaceuticals Inc
11/07/20246:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
11/07/20246:00AMGlobeNewswire Inc.Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)NASDAQ:ETONEton Pharmaceuticals Inc
11/06/20243:30PMGlobeNewswire Inc.Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024NASDAQ:ETONEton Pharmaceuticals Inc
10/04/20243:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETONEton Pharmaceuticals Inc
10/03/20245:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
10/03/20245:30AMGlobeNewswire Inc.Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from IpsenNASDAQ:ETONEton Pharmaceuticals Inc
08/22/20243:30PMGlobeNewswire Inc.Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ETONEton Pharmaceuticals Inc
08/08/20243:25PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ETONEton Pharmaceuticals Inc
08/08/20243:21PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
08/08/20243:01PMGlobeNewswire Inc.Eton Pharmaceuticals Reports Second Quarter 2024 Financial ResultsNASDAQ:ETONEton Pharmaceuticals Inc
08/02/20243:16PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ETONEton Pharmaceuticals Inc
07/30/20244:30PMGlobeNewswire Inc.Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024NASDAQ:ETONEton Pharmaceuticals Inc
07/15/20243:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
07/15/20243:05PMGlobeNewswire Inc.Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)NASDAQ:ETONEton Pharmaceuticals Inc
06/11/20243:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
05/09/20243:25PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ETONEton Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ETON

Your Recent History

USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
AABB
Asia Broadband (PK)
NASDAQ
COOP
Mr Cooper
NYSE
IONQ
IonQ
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
NBRI
North Bay Resources (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
AXXA
Exxe (PK)
NASDAQ
LWLG
Lightwave Logic
NASDAQ
AVXL
Anavex Life Sciences
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
FNMA
Fannie Mae (QB)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
HMBL
HUMBL (PK)
USOTC
BIEL
Bioelectronics (PK)
USOTC
CGAC
Code Green Apparel (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads